Human Papillomavirus (HPV) detection using in situ hybridization in histologic samples

American Journal of Clinical Pathology

Volumn 136, Issue 1, 2011, Pages 119-127

  Kelesidis, Theodoros ^a   Aish, Leo ^b   Steller, Michael A ^b   Aish, Irene S ^b   Shen, Junquing ^b   Foukas, Periklis ^c   Panayiotides, John ^c   Petrikkos, George ^c   Karakitsos, Petros ^c   Tsiodras, Sotirios ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancer; Cervical intraepithelial neoplasia; HPV; Human papillomavirus; In situ hybridization; PCR; Polymerase chain reaction

Indexed keywords

ARTICLE; CYTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 79960128160     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP03HUQYZMWATP     Document Type: Article

References (31)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
2. zur Hausen H. Viruses in human cancers. Science. 1991;254:1167-1173.
3. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385-1394.
4. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249-257.
5. Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103:304-309.
6. Bryan JT, Taddeo F, Skulsky D, et al. Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas. J Med Virol. 2006;78:117-124. (Pubitemid 41783851)
7. Zehbe I, Hacker GW, Su H, et al. Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus. Am J Pathol. 1997;150:1553-1561. (Pubitemid 27193805)
8. Evans MF, Aliesky HA, Cooper K. Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC Clin Pathol. 2003;3:2. doi:10.1186/1472-6890-3-2.
9. Guo M, Gong Y, Deavers M, et al. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol. 2008;46:274-280.
10. Lizard G, Demares-Poulet MJ, Roignot P, et al. In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system: GenPoint. Diagn Cytopathol. 2001;24:112-116.
11. Guo M, Patel SJ, Chovanec M, et al. A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies. Acta Cytol. 2007;51:749-754. (Pubitemid 47443609)
12. Zaravinos A, Mammas IN, Sourvinos G, et al. Molecular detection methods of human papillomavirus (HPV). Int J Biol Markers. 2009;24:215-222.
13. Conesa-Zamora P, Domenech-Peris A, Orantes-Casado FJ, et al. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol. 2009;132:378-390.
14. Griesser H, Sander H, Walczak C, et al. HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions. Am J Clin Pathol. 2009;132:840-845.
15. Huang MZ, Li HB, Nie XM, et al. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Diagn Cytopathol. 2010;38:573-578.
16. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399. (Pubitemid 35239415)
17. Liang J, Mittal KR, Wei JJ, et al. Utility of p16INK4a, CEA, Ki67, p53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol. 2007;26:71-75. (Pubitemid 46036962)
18. Sarian LO, Derchain SF, Yoshida A, et al. Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix. Gynecol Oncol. 2006;102:537-541. (Pubitemid 44353650)
19. Zhang Q, Kuhn L, Denny LA, et al. Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int J Cancer. 2007;120:351-356. (Pubitemid 44956845)
20. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077-1087.
21. Stoler MH. Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing. Arch Pathol Lab Med. 2003;127:935-939. (Pubitemid 36994851)
22. Maucort-Boulch D, Plummer M, Castle PE, et al. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer. 2010;126:684-691.
23. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
24. De Marchi TR, Metze K, Zeferino LC, et al. HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecol Oncol. 2009;112:114-118.
25. Tsiodras S, Georgoulakis J, Chranioti A, et al. Hybrid Capture vs PCR screening of cervical human papilloma virus infections: cytological and histological associations in 1270 women. BMC Cancer. 2010;10:53. doi:10.1186/1471-2407-10-53.
26. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354:20-25. (Pubitemid 29304297)
27. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610. (Pubitemid 29211769)
28. Cooper K, Herrington CS, Stickland JE, et al. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol. 1991;44:990-996.
29. Fujii T, Masumoto N, Saito M, et al. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn Mol Pathol. 2005;14:103-108. (Pubitemid 40734078)
30. Flores-Munguia R, Siegel E, Klimecki WT, et al. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagn. 2004;6:115-124. (Pubitemid 38578987)
31. Fiegl M, Haun M, Massoner A, et al. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol. 2004;22:474-483. (Pubitemid 41079777)